← Open Payments lookup

DELISA GUADARRAMA: Open Payments

NPI 1356637227 · EDINBURG, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,796 in 70 payments from 11 companies in 2025. Trend: 2023 $1,595 · 2024 $1,291 · 2025 $1,796

Food & beverage: $1,796
CompanyPaymentsAmount
Otsuka America Pharmaceutical, Inc.15$497
ABBVIE INC.13$271
Alkermes, Inc.7$230
Corium, LLC13$195
Teva Pharmaceuticals USA, Inc.6$177
Axsome Therapeutics, Inc.4$169
Lundbeck LLC5$112
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)2$51
Takeda Pharmaceuticals U.S.A., Inc.2$36
E.R. Squibb & Sons, L.L.C.2$33

Products named: REXULTI, VRAYLAR, Azstarys, Auvelity, UZEDY, LYBALVI, ARISTADA, ABILIFY ASIMTUFII.

Industry payments across TX — which companies pay providers there.